FDA Approves Eli Lilly Weight Loss Pill

FDA approves Eli Lilly weight loss pill

The FDA approved a new GLP-1 drug from Eli Lilly. Dr. Jon LaPook breaks it down.

As GLP-1 generics flood market, govt intensifies surveillance

India News: NEW DELHI: With prices of GLP-1 drugs crashing and their generic versions flooding the market, govt has cracked down on their misuse, inspecting 49 bu.

Ozempic-style drug in pill form wins key approval

Australian tech health providers say they are keen to offer an oral pill version of the class of GLP-1 medications, which previously required injections.

Nicotine pouch fast-track approvals stalled at FDA, report says

New versions of both Zyn and Velo — both popular nicotine pouch brands — are still pending approval by the FDA

US approves new oral weight-loss pill developed by Eli Lilly

Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s WegovyThe US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arrivi…

Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says

Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.